JP Morgan Chase
CELG

JP Morgan Chase’s Celgene Corp CELG Stock Holding History

JP Morgan Chase’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,354,501
Closed -$929M – 6129
2019
Q3 		$929M Sell
9,354,501
-245,595
-3% -$23.3M 0.19% 119
2019
Q2 		$887M Buy
9,600,096
+2,552,766
+36% +$242M 0.17% 126
2019
Q1 		$665M Buy
7,047,330
+870,872
+14% +$76.2M 0.14% 166
2018
Q4 		$396M Buy
6,176,458
+2,170,525
+54% +$160M 0.09% 234
2018
Q3 		$358M Sell
4,005,933
-333,926
-8% -$29.5M 0.07% 301
2018
Q2 		$345M Sell
4,339,859
-1,068,278
-20% -$88.7M 0.07% 292
2018
Q1 		$482M Sell
5,408,137
-3,550,901
-40% -$341M 0.1% 213
2017
Q4 		$935M Buy
8,959,038
+457,996
+5% +$51.7M 0.2% 108
2017
Q3 		$1.21B Sell
8,501,042
-503,470
-6% -$68.6M 0.27% 75
2017
Q2 		$1.17B Sell
9,004,512
-996,923
-10% -$122M 0.27% 78
2017
Q1 		$1.24B Sell
10,001,435
-357,070
-3% -$42.7M 0.28% 69
2016
Q4 		$1.2B Buy
10,358,505
+1,831,108
+21% +$204M 0.29% 76
2016
Q3 		$892M Sell
8,527,397
-3,867,876
-31% -$419M 0.22% 98
2016
Q2 		$1.22B Sell
12,395,273
-4,138,846
-25% -$428M 0.3% 72
2016
Q1 		$1.65B Sell
16,534,119
-4,655,442
-22% -$479M 0.42% 38
2015
Q4 		$2.54B Sell
21,189,561
-1,117,453
-5% -$129M 0.64% 20
2015
Q3 		$2.41B Buy
22,307,014
+1,200,420
+6% +$149M 0.65% 20
2015
Q2 		$2.44B Buy
21,106,594
+986,330
+5% +$113M 0.58% 27
2015
Q1 		$2.32B Buy
20,120,264
+753,793
+4% +$90.1M 0.53% 28
2014
Q4 		$2.17B Sell
19,366,471
-2,323,600
-11% -$245M 0.5% 27
2014
Q3 		$2.06B Sell
21,690,071
-2,582,616
-11% -$233M 0.49% 34
2014
Q2 		$2.08B Buy
24,272,687
+913,637
+4% +$69.5M 0.53% 29
2014
Q1 		$1.63B Sell
23,359,050
-1,226,232
-5% -$97.1M 0.45% 38
2013
Q4 		$2.08B Buy
24,585,282
+3,090,224
+14% +$245M 0.59% 25
2013
Q3 		$1.66B Buy
21,495,058
+2,291,264
+12% +$161M 0.49% 32
2013
Q2 		$1.12B Buy
+19,203,794
New +$1.16B 0.36% 52

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $341K AUM 32.64% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

JP Morgan Chase's CELG Position: Q4 2019 in Review

JP Morgan Chase sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,354,501 shares — an estimated $929M sold.

JP Morgan Chase first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.54B in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • JP Morgan Chase reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • JP Morgan Chase sold 9,354,501 Celgene Corp shares in Q4 2019, an estimated $929M.
  • JP Morgan Chase first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • JP Morgan Chase's Celgene Corp position peaked at $2.54B in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.